Arranz, Reyes <br/><br/>
Dose-escalated CHOP and tailored intensification with IFE according to early response and followed by BEAM/autologous stem-cell transplantation in poor-risk aggressive B-cell lymphoma: a prospective study from the GEL-TAMO Study Group.  [electronic resource] 

 -  European journal of haematology  Mar 2008 
 - 227-35 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1600-0609 
<br/><br/><label>Standard No.: </label>10.1111/j.1600-0609.2007.01020.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antineoplastic Agents, Phytogenic--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Carmustine--administration & dosage<br/>Combined Modality Therapy<br/>Cyclophosphamide--administration & dosage<br/>Cytarabine--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Drug Administration Schedule<br/>Etoposide--administration & dosage<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Ifosfamide--administration & dosage<br/>Lymphoma, Large B-Cell, Diffuse--drug therapy<br/>Male<br/>Melphalan--administration & dosage<br/>Middle Aged<br/>Podophyllotoxin--administration & dosage<br/>Prednisone--administration & dosage<br/>Prognosis<br/>Prospective Studies<br/>Risk Assessment<br/>Stem Cell Transplantation<br/>Survival Analysis<br/>Transplantation, Autologous<br/>Vincristine--administration & dosage